The Association of Falling Insulin Requirements With Maternal Biomarkers and Placental Dysfunction: A Prospective Study of Women With Preexisting Diabetes in Pregnancy
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
OBJECTIVE To investigate the association of falling insulin requirements (FIR) among women with preexisting diabetes with adverse obstetric outcomes and maternal biomarkers longitudinally in pregnancy. RESEARCH DESIGN AND METHODS A multicenter prospective cohort study of 158 women (41 with type 1 diabetes and 117 with type 2 diabetes) was conducted. Women with FIR of ≥15% from the peak total daily dose after 20 weeks' gestation were considered case subjects (n = 32). The primary outcome was a composite of clinical markers of placental dysfunction (preeclampsia, small for gestational age [≤5th centile], stillbirth, premature delivery [<30 weeks], and placental abruption). Maternal circulating angiogenic markers (placental growth factor [PlGF] and soluble fms-like tyrosine kinase 1 [sFlt-1]), placental hormones (human placental lactogen, progesterone, and tumor necrosis factor-α), HbA1c, and creatinine were studied serially during pregnancy. RESULTS FIR ≥15% were associated with an increased risk of the composite primary outcome (odds ratio [OR] 4.38 [95% CI 1.9–10.3]; P < 0.001), preeclampsia (OR 6.76 [95% CI 2.7–16.7]; P < 0.001), and was more common among women with type 1 diabetes (36.6 vs. 14.5%; P = 0.002). Creatinine was modestly elevated among women with FIR ≥15%; however, there was no difference in HbA1c. The ratio of sFlt-1 to PlGF was significantly higher among women with FIR at 25, 30, and 36 weeks, with differences maintained in the subgroup that developed preeclampsia. There was no difference in placental hormones between the groups. CONCLUSIONS This is the first prospective study to associate FIR with altered expression of placental antiangiogenic factors and preeclampsia. FIR are an important clinical sign, among women with preexisting diabetes, that should alert the clinician to investigate underlying placental dysfunction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A rapid reduction in insulin requirements can indicate the development of placental insufficiency (32).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [32]
Citations
Cites
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1414838 · Cited by 1,783
Tranquilli, A. L., Dekker, G., Magee, L., Roberts, J., Sibai, B. M., Steyn, W., Zeeman, G. G., & Brown, M. A. (2014) · Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health · doi:10.1016/j.preghy.2014.02.001 · Cited by 1,417
TNF-α Is a Predictor of Insulin Resistance in Human Pregnancy
Kirwan, J. P., Hauguel-De Mouzon, S., Lepercq, J., Challier, J.-C., Huston-Presley, L., Friedman, J. E., Kalhan, S. C., & Catalano, P. M. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2207 · Cited by 738
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia
Rana, S., Powe, C. E., Salahuddin, S., Verlohren, S., Perschel, F. H., Levine, R. J., Lim, K.-H., Wenger, J. B., Thadhani, R., & Karumanchi, S. A. (2012) · Circulation · doi:10.1161/circulationaha.111.054361 · Cited by 668
Verlohren, S., Herraiz, I., Lapaire, O., Schlembach, D., Moertl, M., Zeisler, H., Calda, P., Holzgreve, W., Galindo, A., Engels, T., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.07.037 · Cited by 448
Cited by
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 268
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
Indications for Outpatient Antenatal Fetal Surveillance: ACOG Committee Opinion, Number 828
(2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004407 · Cited by 135
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 176
SCOTT, E. M., Murphy, H. R., Kristensen, K. H., Feig, D. S., Kjölhede, K., Englund‐Ögge, L., Berntorp, K. E., & Law, G. R. (2022) · Diabetes Care · doi:10.2337/dc22-0078 · Cited by 104
Sibiak, R., Jankowski, M., Gutaj, P., Mozdziak, P. E., Kempisty, B., & Wender-Ożegowska, E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041142 · Cited by 106
“reporting no differences in PL, progesterone, and TNF-α blood concentrations in women with decreasing insulin requirements [83].”
BackgroundADIPS 2020 guideline for pre‐existing diabetes and pregnancy
Rudland, V. L., Price, S., Hughes, R. C. E., Barrett, H. L., Lagstrom, J., Porter, C., Britten, F. L., Glastras, S. J., Fulcher, I., Wein, P., et al. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13265 · Cited by 90
Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
Nuzzo, A. M., Giuffrida, D., Moretti, L., Re, P., Grassi, G., Menato, G., & Rolfo, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-81785-5 · Cited by 72
Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes
Meek, C. L., Tundidor, D., Feig, D. S., Yamamoto, J. M., SCOTT, E. M., Ma, D.-D., Halperin, J. A., Murphy, H. R., Corcoy, R., & the CONCEPTT collaborative group (2021) · Diabetes Care · doi:10.2337/dc20-2360 · Cited by 68
“function or placental dysfunction with ensuing lower insulin requirements (reverse causation) (26).”
BackgroundFeig, D. S., Zinman, B., Asztalos, E. V., Donovan, L., Shah, P. S., Sanchez, J., TOMLINSON, G. A., & Murphy, K. E. (2022) · Diabetes Care · doi:10.2337/dc22-0013 · Cited by 41
Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes
Søholm, J. C., Vestgaard, M. J., Ásbjörnsdóttir, B., Do, N. C., Pedersen, B. W., Storgaard, L., Nielsen, B. B., Ringholm, L., Damm, P., & Mathiesen, E. R. (2021) · Diabetologia · doi:10.1007/s00125-021-05482-8 · Cited by 37
“Falling insulin requirements have been associated with both preeclampsia and preterm delivery [15, 39].”
BackgroundResultBenhalima, K., Durnwald, C. P., Sweeting, A., Adams, D., Addala, A., Battelino, T., Bergenstal, R. M., Carlson, A. L., Donovan, L., Franco, D. R., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00335-3 · Cited by 38
Altered Expression of Angiogenic Biomarkers in Pregnancy Associated with Gestational Diabetes
Al-ofi, E. A., Alrafiah, A., Maidi, S., Almaghrabi, S., & Hakami, N. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s316670 · Cited by 33
Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes
McLean, A., Barr, E., Tabuai, G., Murphy, H. R., & Maple-Brown, L. J. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0300 · Cited by 28
“Other possible contributors include a component of increased insulin sensitivity and/or placental insufficiency in late pregnancy contributing to hypoglycemia in some women, 26 or increased inaccuracy of the Libre 1 system throughout pregnancy.”
BackgroundKarpova, N. S., Dmitrenko, O., & Сергеевна, Б. Т. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076744 · Cited by 31
Zen, M., Padmanabhan, S., Zhang, K., Kirby, A. C., Cheung, N. W., Lee, V. W., & Alahakoon, T. I. (2019) · Diabetes Care · doi:10.2337/dc19-0967 · Cited by 22
“Previous termination 14 (9) 12 (9) 2 (7) 0.”
BackgroundSelf-citationChen, Q., Dai, W., Sun, Y., Zhao, F., Liu, J., & Liu, H. (2018) · Nutrients · doi:10.3390/nu10091190 · Cited by 19
“A high physiological level of insulin is required to promote fetal growth and development, whereas low insulin levels, such as in diabetic pregnancy, may lead to an increased risk of congenital abnormalities [27].”
BackgroundPlacental and plasma early predictive biomarkers for gestational diabetes mellitus
Wei, Y., He, A., Huang, Z., Liu, J., & Li, R. (2022) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202200001 · Cited by 15
Shaltout, I., Abdelwahab, A. M., Meligi, A. A. H. E., Hammad, H., Abdelghaffar, S., Elbahry, A., Taha, N., Elsaid, N. H., Gad, A., Hammouda, L. M., et al. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998249793231005105724 · Cited by 19
“Also, placental insufficiency presents in the third trimester with unwarranted hypoglycemia, especially if associated with falling insulin requirements [73].”
Søholm, J. C., Do, N. C., Vestgaard, M. J., Ásbjörnsdóttir, B., Nørgaard, S. K., Pedersen, B. W., Storgaard, L., Nielsen, B. B., Holmager, P., Ringholm, L., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac159 · Cited by 11
Zen, M., Padmanabhan, S., Cheung, N. W., Kirby, A. C., Jesudason, S., Alahakoon, T. I., & Lee, V. W. (2019) · Pregnancy Hypertension · doi:10.1016/j.preghy.2019.01.010 · Cited by 13
Self-citationSweeting, A., Hsieh, A., Wong, J., & Ross, G. P. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1900104 · Cited by 9
“Insulin resistance in pregnancy is primarily due to placental hormone-insulin receptor binding interactions [23]; conversely, placental insufficiency is associated with decreasing insulin resistance [24], presumably arising from less robust hormone production.”
BackgroundFalling insulin requirement in late pregnancy: association with obstetric and neonatal outcomes
Wilkinson, B. E., McDonnell, M. E., Palermo, N. E., Lassey, S. C., & Little, S. (2021) · Journal of Perinatology · doi:10.1038/s41372-021-00979-x · Cited by 8
Finnegan, C. L., Dicker, P., Asandei, D. R., Higgins, M., O’Gorman, N., Riordan, M. O., Dunne, F., Gaffney, G., Newman, C., McAuliffe, F. M., et al. (2024) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2024.101297 · Cited by 10
Park, C.-Y., Sung, J.-H., Kim, K.-S., & Han, K. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0444 · Cited by 8
“25,26 An animal study showing improved glucose homeostasis in progesterone receptor knockout mice supports the adverse effect of progesterone on glucose tolerance and insulin release.”
BackgroundMcCance, D. R., & Cassidy, L. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch71 · Cited by 9
Suboptimally Controlled Diabetes in Pregnancy: A Review to Guide Antepartum and Delivery Management
Cate, J. J. M., Bloom, E. A., Chu, A., Bauer, S., Kuller, J. A., & Dotters-Katz, S. K. (2024) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001270 · Cited by 7
Padmanabhan, S., Lee, V. W., McLean, M. P., Athayde, N., Lanzarone, V., Peek, M. J., Quinton, A. E., & Cheung, N. W. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2022.2122803 · Cited by 4
“ical markers of placental dysfunction and FIR [2,3]”
BackgroundMethodSelf-citationMikuscheva, A., Mekhail, A., & Wheeler, B. J. (2018) · Case Reports in Obstetrics and Gynecology · doi:10.1155/2018/9451061 · Cited by 4
“Based on the above findings the current clinical recommendation for all women manifesting FIR ≥ 15% is for increased surveillance and investigation for adverse obstetric outcomes; however, its presence does not necessarily indicate urgent, immediate delivery [11].”
Escobar, G. M. V., Li, L., Cheng, W., Li, Z., Gao, Q. F., Sun, J., & Hao, L. (2025) · Food, Nutrition and Health. · doi:10.1007/s44403-025-00041-0 · Cited by 9
“By the end of the third trimester, insulin requirements tend to stabilize as the placenta begins to age [24].”
D'Souza, R. D., Ashraf, R., Sayfi, S., Prior, A., Pihelgas, A., Sanni, O. B., Sayyar, P., Alavifard, S., Ospina, M. B., & Jain, V. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207357 · Cited by 4
“Only one study provided details on the collection of data on dietary intake and did a sensitivity analysis by excluding those with reduction in carbohydrate intake [33].”
InfluentialFalling insulin requirements — a red flag for pre-eclampsia
Holmes, D. I. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.114 · Cited by 3
Type 1 diabetes and pregnancy: An update on glucose monitoring and insulin treatment
Amigó, J., & Corcoy, R. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2022.06.008 · Cited by 2
Park, C., Sung, J., Kim, K., & Han, K. (2023) · doi:10.22541/au.168373084.40040135/v1 · Cited by 2
Vainder, M., Natt, N., Sayyar, P., Syeda, A., Ashraf, R., Mitsakakis, N., Feig, D. S., Kingdom, J. C., & D'Souza, R. D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217737 · Cited by 3
“A subsequent prospective study by the same group showed a correlation between a drop in IR after 20 weeks gestation and a composite of clinical markers of placental dysfunction [19].”
InfluentialAdvances in diabetes technology: clinical implications, limitations, and future perspectives
Apostolopoulou, M., & Effraimidis, G. (2026) · HORMONES · doi:10.1007/s42000-026-00797-w · Cited by 2
Type 1 Diabetes: During Preconception, Pregnancy, Postpartum, and Breastfeeding
Yamamoto, J. M., & Donovan, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00023-4 · Cited by 1
Amigó, J., & Corcoy, R. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.09.005 · Cited by 2
Continuous glucose monitoring metrics in pregnancy with type 1 diabetes mellitus
Jeeyavudeen, M. S., Crosby, M., & Pappachan, J. M. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i1.90316 · Cited by 5
Le diabète gestationnel : diagnostic et prise en charge
Meykiechel, T., Bourcigaux, N., & Christin‐Maître, S. (2023) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2023.05.002 · Cited by 8
Pihelgas, A., Prior, A., Ospina, M. B., & Jain, V. (2021) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2020.12.015
Anderson, A. (2020) · ScholarWorks - UA (University of Alaska System)
Jang, H. N., & Jung, H. S. (2021) · Stroke revisited · doi:10.1007/978-981-16-5123-6_17
Attention à la chute des besoins en insuline durant la grossesse !
(2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30151-7
Landon, M. B., & Gabbe, S. G. (2020) · Wiley eBooks · doi:10.1002/9781119635307.ch22
Alojayli, A. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.49.007851
Pregnancy monitoring in women with type 1 diabetes – actual protocol
Dumitrescu, R. D., & Avram, C. (2024) · Medic ro · doi:10.26416/med.161.5.2024.10241
Type 1 Diabetes: During Preconception, Pregnancy, Postpartum, Breastfeeding
Yamamoto, J. M., & Donovan, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00018-1
Truong, Q., Gomola, K., Li, L., Hare, M. J. L., & McLean, A. (2026) · Research Square · doi:10.21203/rs.3.rs-8177369/v1
Morton, A., Raghunath, V., & He, J. (2026) · Obstetric Medicine · doi:10.1177/1753495x261418194
Zhang, K., Alahakoon, T. I., Shaw, A., CHEUNG, N. W., Lee, V. W., & Padmanabhan, S. (2026) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70278
Self-citation
Metadata
- Authors
- Padmanabhan, S., Lee, V. W., Mclean, M., Athayde, N., Lanzarone, V., Khoshnow, Q., Peek, M. J., & Cheung, N. W.
- Affiliations
- The University of Sydney (AU)
- Blacktown & Mount Druitt Hospital (AU)
- Westmead Hospital (AU)
- Nepean Hospital (AU)
- Australian National University (AU)
- Corresponding author
- Padmanabhan, Suja
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-10
- Volume
- 40
- Issue
- 10
- Pages
- 1323-1330
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2742424235
- Cited by
- 55
- References
- 40
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 11 · 2020: 5 · 2019: 4 · 2018: 2 · 2017: 2
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- type 1 diabetes, type 2 diabetes, placental insufficiency, preeclampsia, angiogenic biomarkers, small for gestational age, stillbirth, placental abruption, human placental lactogen, placental hormones, maternal biomarkers, adverse obstetric outcomes
- MeSH terms
- Adult, Creatinine, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Female, Glycated Hemoglobin, Humans, Infant, Infant, Small for Gestational Age, Insulin, Placenta, Placental Hormones, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Pregnancy Outcome, Prospective Studies, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.